Moleculin Biotech Balance Sheet (2016-2025) | MBRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	86.30M	79.50M	75.20M	70.90M	66.10M	58.00M	50.40M	43.15M	37.30M	32.20M	24.60M	23.55M	16.82M	10.85M	9.40M	4.28M	7.72M	7.56M	6.70M	8.88M
Receivables - Net (Quarter)								0.02M		0.01M
Receivables - Other (Quarter)				0.02M	0.01M	0.03M	0.00M	0.00M		0.01M		0.10M		0.01M		0.02M	0.00M	0.00M	0.00M	0.01M
Receivables (Quarter)								0.02M		0.01M
Prepaid Assets (Quarter)	1.73M	2.33M	1.89M	0.59M	1.16M	3.32M	3.10M	2.45M	2.02M	3.21M	3.02M	0.56M	2.13M	1.14M	2.20M	0.92M	0.29M	1.07M	0.79M	0.81M
Current Assets (Quarter)	88.02M	81.84M	77.07M	72.50M	67.26M	61.32M	53.49M	45.60M	39.29M	35.38M	27.60M	26.27M	18.96M	13.73M	11.61M	5.19M	9.34M	9.08M	7.88M	9.69M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.44M	0.40M	0.35M	0.34M	0.31M	0.34M	0.31M	0.28M	0.24M	0.23M	0.23M	0.27M	0.24M	0.22M	0.19M	0.16M	0.13M	0.10M	0.08M	0.08M
Intangibles (Quarter)				11.10M				11.10M				11.10M				11.10M				11.10M
Goodwill & Intangibles (Quarter)	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M	11.15M
Other Non-Current Assets (Quarter)																		0.90M	0.90M	0.90M
Non-Current Assets (Quarter)	11.77M	11.70M	11.63M	11.59M	11.54M	11.93M	11.88M	11.83M	11.77M	11.73M	11.92M	11.94M	11.89M	11.84M	11.79M	11.73M	11.67M	12.52M	12.47M	12.44M
Assets (Quarter)	99.78M	93.53M	88.70M	84.09M	78.80M	73.25M	65.37M	57.42M	51.06M	47.12M	39.52M	38.22M	30.84M	25.57M	23.39M	16.93M	21.01M	21.59M	20.35M	22.13M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.93M	1.50M	1.39M	1.36M	2.22M	3.18M	3.57M	2.10M	1.94M	4.14M	2.01M	2.50M	2.10M	2.83M	2.55M	2.03M	2.71M	3.72M	2.12M	3.51M
Notes Payables (Quarter)
Payables (Quarter)	1.93M	1.50M	1.39M	1.36M	2.22M	3.18M	3.57M	2.10M	1.94M	4.14M	2.01M	2.50M	2.10M	2.83M	2.55M	2.03M	2.71M	3.72M	2.12M	3.51M
Accumulated Expenses (Quarter)	2.65M	0.11M	0.35M	2.26M	1.03M	2.67M	2.79M	0.75M	3.09M	2.42M	1.88M	0.77M	3.30M	1.16M	3.04M	1.82M	4.19M	4.19M	1.35M	1.82M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)	0.10M			0.11M	0.12M	0.10M	0.11M	0.09M
Current Leases (Quarter)	0.12M			0.10M	0.08M	0.10M	0.11M	0.12M
Total Current Liabilities (Quarter)	4.58M	3.35M	3.66M	3.62M	4.83M	5.86M	6.36M	4.82M	5.03M	6.55M	3.89M	6.82M	5.41M	5.75M	5.59M	5.36M	6.90M	7.91M	5.68M	6.85M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)	0.25M	0.09M	0.07M	0.06M	0.05M	0.39M	0.36M	0.34M	0.31M	0.29M	0.50M	0.47M	0.45M	0.42M	0.39M	0.36M	0.33M	0.29M	0.26M	0.22M
Other Non-Current Liabilities (Quarter)	6.56M	5.39M	3.71M	1.41M	1.25M	0.65M	0.23M	0.08M	0.04M	0.00M	0.00M	4.86M	3.40M	1.70M	9.93M			16.97M	41.33M	0.04M
Total Non-Current Liabilities (Quarter)	4.71M	3.44M	3.73M	3.69M	4.88M	6.25M	6.73M	5.15M	5.34M	6.84M	4.38M	7.29M	5.86M	6.17M	5.98M	5.72M	7.22M	8.21M	5.94M	7.08M
Total Liabilities (Quarter)	11.27M	8.83M	7.44M	5.10M	6.14M	6.90M	6.96M	5.23M	5.38M	6.85M	4.38M	12.14M	9.26M	7.87M	15.91M	5.72M	7.22M	25.18M	47.27M	7.12M
Shareholder's Equity
Total Debt (Quarter)	0.10M			0.11M	0.12M	0.10M	0.11M	0.09M
Common Equity (Quarter)	88.52M	84.70M	81.26M	78.99M	72.67M	66.36M	58.42M	52.19M	45.68M	40.27M	35.14M	30.93M	24.99M	19.41M	17.41M	11.21M	13.79M	-3.58M	-26.92M	15.01M
Shareholder's Equity (Quarter)	88.52M	84.70M	81.26M	78.99M	72.67M	66.36M	58.42M	52.19M	45.68M	40.27M	35.14M	30.93M	24.99M	19.41M	17.41M	11.21M	13.79M	-3.58M	-26.92M	15.01M
Liabilities and Shareholders Equity (Quarter)	99.78M	93.53M	88.70M	84.09M	78.80M	73.25M	65.37M	57.42M	51.06M	47.12M	39.52M	38.22M	30.84M	25.57M	23.39M	16.93M	21.01M	21.59M	20.35M	22.13M
Retained Earnings (Quarter)	-61.36M	-65.60M	-70.00M	-72.81M	-79.70M	-86.50M	-95.06M	-101.83M	-109.80M	-115.73M	-121.33M	-131.60M	-136.57M	-140.89M	-151.49M	-172.44M	-178.35M	-196.16M	-221.60M	-206.00M
Treasury Shares (Quarter)				0.22M				0.04M				0.09M				0.00M				0.06M
Shares Outstanding (Quarter)	28.44M	28.55M	28.58M	1.91M	28.58M	28.61M	28.63M	1.91M	1.97M	1.99M	1.99M	0.09M	2.31M	2.56M	3.00M	0.14M	14.13M	30.21M	49.50M	3.20M

Research Tools

Moleculin Biotech Balance Sheet (2016-2025) | MBRX

Create an account

Sign In

Reset Password